B
Boundless Bio Inc
NASDAQ:BOLD
Boundless Bio Inc
NASDAQ:BOLD
Price:
2.83
USD
0.71%
Market Cap:
$63.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Boundless Bio Inc
NASDAQ:BOLD
|
US |
|
CVS Health Corp
NYSE:CVS
|
US |
|
N
|
Nissin Foods Holdings Co Ltd
SWB:NF2
|
JP |
|
Buckle Inc
NYSE:BKE
|
US |
|
H
|
Heidelberg Materials AG
SWB:HEI
|
DE |
|
1
|
1606 Corp
OTC:CBDW
|
US |
|
B
|
BIOAGE Labs Inc
NASDAQ:BIOA
|
US |
|
S
|
Sichuan Hongda Co Ltd
SSE:600331
|
CN |
|
D
|
Dakota Gold Corp
F:RR6
|
US |
|
Lotte Corp
KRX:004990
|
KR |
|
Hertz Global Holdings Inc
F:AZK0
|
US |
|
Hochiki Corp
TSE:6745
|
JP |
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
AU |
|
Toho Co Ltd (Tokyo)
OTC:TKCOF
|
JP |
|
Sekisui Chemical Co Ltd
F:SUI
|
JP |
|
Prima Andalan Mandiri Tbk PT
IDX:MCOL
|
ID |
|
Prada SpA
OTC:PRDSF
|
IT |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of BOLD.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BOLD
Multiples-Based Value
Base Case
Not Available